BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 19339640)

  • 1. What can we expect from omega-3 fatty acids?
    Chan EJ; Cho L
    Cleve Clin J Med; 2009 Apr; 76(4):245-51. PubMed ID: 19339640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans.
    Mori TA; Woodman RJ
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):95-104. PubMed ID: 16477172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
    Bays HE; Tighe AP; Sadovsky R; Davidson MH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study.
    De Luis DA; Conde R; Aller R; Izaola O; González Sagrado M; Perez Castrillón JL; Dueñas A; Romero E
    Eur Rev Med Pharmacol Sci; 2009; 13(1):51-5. PubMed ID: 19364085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of omega-3 fatty acids in cardiovascular disease.
    Saremi A; Arora R
    Am J Ther; 2009; 16(5):421-36. PubMed ID: 19092647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
    Lavie CJ; Milani RV; Mehra MR; Ventura HO
    J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis.
    Holub BJ
    CMAJ; 1988 Sep; 139(5):377-81. PubMed ID: 2842022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
    Skulas-Ray AC; West SG; Davidson MH; Kris-Etherton PM
    Expert Opin Pharmacother; 2008 May; 9(7):1237-48. PubMed ID: 18422480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collateral benefits of fish oil therapy for rheumatoid arthritis.
    Lau CS
    J Rheumatol; 2006 Oct; 33(10):1931-3. PubMed ID: 17014011
    [No Abstract]   [Full Text] [Related]  

  • 13. Omega-3 fatty acids and the cardiometabolic syndrome.
    Juturu V
    J Cardiometab Syndr; 2008; 3(4):244-53. PubMed ID: 19040594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer eggs: best way to get your omega-3 fatty acids?
    Consum Rep; 2004 Aug; 69(8):45. PubMed ID: 15243993
    [No Abstract]   [Full Text] [Related]  

  • 15. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review.
    Weber P; Raederstorff D
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):28-37. PubMed ID: 10812585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sources of the very-long-chain unsaturated omega-3 fatty acids: eicosapentaenoic acid and docosahexaenoic acid.
    Racine RA; Deckelbaum RJ
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):123-8. PubMed ID: 17284998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.
    Ebrahimi M; Ghayour-Mobarhan M; Rezaiean S; Hoseini M; Parizade SM; Farhoudi F; Hosseininezhad SJ; Tavallaei S; Vejdani A; Azimi-Nezhad M; Shakeri MT; Rad MA; Mobarra N; Kazemi-Bajestani SM; Ferns GA
    Acta Cardiol; 2009 Jun; 64(3):321-7. PubMed ID: 19593941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
    Harris WS; Dayspring TD; Moran TJ
    Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish oil and heart health.
    de Leiris J; de Lorgeril M; Boucher F
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):378-384. PubMed ID: 19568180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the environment for regulatory change for eicosapentaenoic acid and docosahexaenoic acid nutrition labeling.
    Brownawell AM; Harris WS; Hibbeln JR; Klurfeld DM; Newton I; Yates A
    Nutr Rev; 2009 Jul; 67(7):391-7. PubMed ID: 19566599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.